Late Preterm Corticosteroids and Neonatal Hypoglycemia

Status unconfirmed · Phase 4

Conditions studied: Neonatal Hypoglycemia, Prematurity

In brief

This is a prospective randomized controlled trial investigating the timing of betamethasone administration in late preterm infants in relation to delivery and impact on neonatal hypoglycemia. Previous data has shown that neonatal hypoglycemia is increased in late preterm infants that were exposed to antenatal corticosteroids. The investigators hypothesize that the timing of steroid administration may impact the development of neonatal hypoglycemia.

Key facts

Study ID

NCT04869709

Run by

University of Southern California

People needed

210

Starts

2021-07-01

Expected to finish

2024-07-01

Last updated by the study team

2021-05-03

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Singleton pregnancy
• Gestational age 34 0/7 weeks to 36 5/7 weeks
• Planned delivery in late preterm period

You may not qualify if…

• Prior course of betamethasone during pregnancy
• Twin gestation
• Fetal demise
• Major fetal anomaly
• Maternal contraindication to betamethasone
• Pregestational diabetes
• Expected delivery within 12 hours of randomization

Where it is running

• LAC+USC Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.